Compare Heron Therapeutics Inc (HRTX) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Heron Therapeutics Inc trades at $0.36 (market cap $68.01M), while Iovance Biotherapeutics Inc. Common Stock trades at $13.43 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 88.8× Heron Therapeutics Inc's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| HRTX | IOVA | |
|---|---|---|
Market Cap | $68.01M | $6.04B |
Volume | 1,891,941 | 14,805,993 |
Sector | Health | Health |
52-Week High | $1.49 | $14.82 |
52-Week Low | $0.27 | $1.81 |
Typical Hold Time | 35 Days | 0 Days |
Enterprise Value | $174.75M | $5.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.
While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
